Pushkarmool in Ayurveda: Properties & Everyday Use

What it is

Pushkarmool, also spelled Pushkarmoola, Puskarmool or Pushkaramula, is the dried root of Inula racemosa Hook. f., a tall herbaceous perennial of the daisy family (Asteraceae) that grows in the temperate western Himalayas between about 1,600 and 4,200 m (Sharma & Dash, Journal of Ayurveda and Integrative Medical Sciences). A distinctive feature of the root is its camphor-like smell (same review).

The root is chemically distinctive: its main constituents are sesquiterpene lactones, notably alantolactone and isoalantolactone, along with compounds such as β-sitosterol (same review). Constituent presence is a basis for hypotheses: not evidence of clinical effect.

Classical properties

• Taste (rasa): bitter (Tikta), pungent (Katu)
• Qualities (guna): light (Laghu), dry (Ruksha)
• Potency (virya): warming (Ushna)
• After digestion (vipaka): pungent (Katu)
• Doshas: traditionally said to settle Vata and Kapha; may increase Pitta

Traditional use

Pushkarmool is one of Ayurveda's principal herbs for the chest. The JAIMS review records classical indications including cough (kasa), asthma and breathlessness (swasa), hiccups (hikka), flank pain (parshwashool) and heart disorders (hritroga) (Sharma & Dash). An institutional medicinal-plants monograph from SSMD Ayurvedic College similarly frames it as a respiratory and cardiac herb in Ayurvedic practice (monograph). These are traditional uses: the human trial evidence is assessed separately below.

What research has looked at

Heart conditions (preclinical only)

Pushkarmool's most-studied modern signal is cardioprotection: but only in animals. In a rat model of isoproterenol-induced myocardial injury, an Inula racemosa root extract showed protective effects (Indian Journal of Biochemistry & Biophysics, via NIScPR). Other animal studies have tested its extracts in related cardiac models (JAIMS review). Protective effects in a rat heart-injury model are not evidence that pushkarmool treats angina, heart disease or any cardiac condition in people.

The one hopeful sign on the horizon is a study protocol published in 2025: a planned double-blind randomized controlled trial testing Pushkar Guggulu (a combination formula containing pushkarmool) plus Haritaki as adjuncts to standard care for stable coronary artery disease (BMC Complementary Medicine and Therapies protocol). It is a protocol, a statement of intent, with no results yet, and even when completed it will test a combination, not pushkarmool alone.

Respiratory conditions

The evidence for cough and asthma is essentially traditional. Small, older reports, including one in nine subjects, and combination-formula studies are cited in reviews, but they are uncontrolled or tiny and cannot support efficacy claims (JAIMS review).

What the evidence does not support (yet)

No randomized, placebo-controlled trial of pushkarmool, alone or in combination, has been published for any condition. That includes angina, coronary artery disease, asthma and cough. Its antioxidant, antimicrobial, antidiabetic and hepatoprotective activities are laboratory or animal findings (JAIMS review).

Safety notes

The recent JAIMS evidence review of Inula racemosa did not identify any published human safety studies: no systematic toxicity work, no pregnancy or breastfeeding data, and no documented drug-interaction profile (JAIMS review). The absence of safety data is a reason for caution, not reassurance: especially for a herb traditionally used for heart and lung conditions, where the stakes of delaying standard care are high.

Anyone with a cardiac diagnosis, angina, breathlessness, asthma or hypertension should treat pushkarmool as strictly complementary: it must never be used to replace prescribed cardiac or respiratory medication, and new chest pain or worsening breathlessness needs emergency medical care, not a herbal trial. Because Inula racemosa belongs to the daisy family (Asteraceae) (same review), people with known Asteraceae allergies should be especially cautious. Use during pregnancy and breastfeeding is not established as safe.

FAQs

What is pushkarmool used for in Ayurveda?

Pushkarmool (the root of Inula racemosa) is Ayurveda's classical chest herb: classical texts use it for cough, asthma/breathlessness, hiccups and heart disorders (hritroga) (JAIMS review). These are traditional uses, not proven effects.

Is pushkarmool good for the heart?

Not proven. Animal studies show protective effects in a rat model of heart injury (IJBB via NIScPR), but no human trial of pushkarmool, alone or in combination, has been published for any heart condition. A 2025 protocol describes a planned RCT of a pushkarmool-containing combination for stable coronary artery disease, with no results yet (BMC protocol).

What is Pushkar Guggulu?

A classical polyherbal formulation containing pushkarmool (among other ingredients) used traditionally for chest and heart complaints (JAIMS review). It is the combination being tested as an adjunct to standard care in the planned 2025 coronary-artery-disease trial (BMC protocol).

What is the dose of pushkarmool?

Swastik does not suggest amounts. The right amount depends on the person, the preparation and the product, so check with a qualified Ayurvedic practitioner or your doctor before taking any herb.

Can pushkarmool replace heart or asthma medication?

No. There are no human efficacy trials, and cardiac and respiratory conditions can deteriorate quickly. Pushkarmool should only ever be considered complementary to, never a substitute for, prescribed treatment.

Is pushkarmool safe in pregnancy?

Safety in pregnancy and breastfeeding has not been established: there are no data. Avoid use, or use only with qualified medical supervision.

Sources

• Sharma S, Dash P. "Pushkarmool (Inula racemosa): A review." Journal of Ayurveda and Integrative Medical Sciences (JAIMS) — jaims.in
• "Medicinal Plants: Pushkaramula." SSMD Ayurvedic College monograph — ssmdayurvediccollege.com
• "Cardioprotective effect of Inula racemosa against isoproterenol-induced myocardial infarction in rats." Indian Journal of Biochemistry & Biophysics (via NIScPR) — nopr.niscpr.res.in
• "Efficacy and safety of Pushkar Guggulu and Haritaki as adjuvant therapy in stable coronary artery disease: study protocol for a randomized, double-blind, placebo-controlled trial." BMC Complementary Medicine and Therapies. 2025 — link.springer.com

Disclaimer

This article is for educational purposes only and is not medical advice. Herbal products can interact with medications and are not suitable for everyone. Talk to a qualified healthcare practitioner before use — especially if you are pregnant, breastfeeding, managing a medical condition, or taking prescription medicines.